These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 4058683)
1. Cholecystokinin octapeptides influence tolerance to ethanol in mice. Szabó G; Kovács GL; Penke B; Telegdy G Neuropeptides; 1985 Sep; 6(5):397-404. PubMed ID: 4058683 [TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin-octapeptide-induced hypothermia in rats: dose-effect and structure-effect relationships, effect of ambient temperature, pharmacological interactions and tolerance. Kapás L; Obál F; Penke B; Obál F Neuropharmacology; 1987; 26(2-3):131-7. PubMed ID: 3587528 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice. Kádár T; Pesti A; Penke B; Tóth G; Zarándi M; Telegdy G Neuropharmacology; 1983 Oct; 22(10):1223-9. PubMed ID: 6316193 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration. Kádár T; Pesti A; Penke B; Telegdy G Neuropharmacology; 1984 Aug; 23(8):955-61. PubMed ID: 6090968 [TBL] [Abstract][Full Text] [Related]
5. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice. Kádár T; Borda L; Penke B; Kovács K; Telegdy G Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response. Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of haloperidol-induced catalepsy by cholecystokinin octapeptides after central administration to rats. Kádár T; Penke B; Kovács K; Telegdy G Neuropharmacology; 1985 Jun; 24(6):577-80. PubMed ID: 2862602 [TBL] [Abstract][Full Text] [Related]
8. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats. Fekete M; Lengyel A; Hegedüs B; Penke B; Zarándy M; Tóth G; Telegdy G Eur J Pharmacol; 1984 Feb; 98(1):79-91. PubMed ID: 6325212 [TBL] [Abstract][Full Text] [Related]
9. CCK receptor activation may prevent tolerance to morphine in mice. Rezayat M; Nikfar S; Zarrindast MR Eur J Pharmacol; 1994 Mar; 254(1-2):21-6. PubMed ID: 8206114 [TBL] [Abstract][Full Text] [Related]
10. The effects of neurohypophyseal hormones on tolerance to the hypothermic effect of ethanol. Szabó G; Kovács GL; Székeli S; Telegdy G Alcohol; 1985; 2(4):567-74. PubMed ID: 4026981 [TBL] [Abstract][Full Text] [Related]
11. Multiple treatment potentiates the anticonvulsive activity of cholecystokinin octapeptides. Kádár T; Penke B; Pesti A; Telegdy G Peptides; 1985; 6(6):1009-14. PubMed ID: 3834411 [TBL] [Abstract][Full Text] [Related]
12. Rapid development of tolerance to the hypothermic effect of ethanol in mice. Crabbe JC; Rigter H; Uijlen J; Strijbos C J Pharmacol Exp Ther; 1979 Jan; 208(1):128-33. PubMed ID: 759607 [TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat. Szelényi Z; Barthó L; Székely M; Romanovsky AA Brain Res; 1994 Feb; 638(1-2):69-77. PubMed ID: 8199877 [TBL] [Abstract][Full Text] [Related]
14. Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide. Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Duda A; Pierzchalski P; Bielański W; Hahn EG Eur J Pharmacol; 1999 Jun; 374(2):263-76. PubMed ID: 10422768 [TBL] [Abstract][Full Text] [Related]
15. Sulphated cholecystokinin octapeptide inhibits ethanol consumption in the rat. Kulkosky PJ; Chavez MR Alcohol; 1984; 1(5):409-12. PubMed ID: 6100357 [TBL] [Abstract][Full Text] [Related]
16. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat. Katsuura G; Itoh S Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507 [TBL] [Abstract][Full Text] [Related]
17. Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide. Kádár T; Penke B; Kovács K; Telegdy G Physiol Behav; 1985 Mar; 34(3):395-400. PubMed ID: 4011720 [TBL] [Abstract][Full Text] [Related]
18. Effects of cholecystokinin on apomorphine-induced changes of motility in rats. Katsuura G; Itoh S; Rehfeld JF Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021 [TBL] [Abstract][Full Text] [Related]
19. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibres and CCKA receptors. Evangelista S; Maggi CA Br J Pharmacol; 1991 Jan; 102(1):119-22. PubMed ID: 2043917 [TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone. Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]